Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.6160
+0.0160 (2.67%)
At close: Jul 20, 2026, 4:00 PM EDT
0.6198
+0.0038 (0.62%)
After-hours: Jul 20, 2026, 7:44 PM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $56.6 million as of July 20, 2026. Its market cap has decreased by -29.11% in one year.
Market Cap
56.60M
Enterprise Value
1.53M
1-Year Change
-29.11%
Ranking
Category
Stock Price
$0.62
ChartMarket Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $56.60M, an increase of 10.91%. That is a compound annual growth rate of 2.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 56.60M | -58.10% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 59.31M |
| Edesa Biotech | 58.69M |
| Boundless Bio | 55.71M |
| Veraxa Biotech AG | 54.97M |
| Xilio Therapeutics | 53.13M |
| MiNK Therapeutics | 53.11M |
| BeyondSpring | 53.04M |
| Seres Therapeutics | 51.62M |